“Open-Label Study (ARIDO) Evaluating Long-Term Safety of Topical Glycopyrronium Tosylate (GT) in Patients With Primary Axillary Hyperhydrosis”. SKIN The Journal of Cutaneous Medicine, vol. 2, no. S1, Feb. 2018, p. S40, https://doi.org/10.25251/skin.2.supp.40.